Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |